AUG 28, 2018 10:37 PM PDT

Alternative Therapy for Peripheral Artery Disease

WRITTEN BY: Nouran Amin

Image Credit: conehealth.com

To fight peripheral artery diseases (PAD), an “ailment affecting 8 million Americans”, researchers at LSU School of Veterinary Medicine have discovered two drugs found in red wine that may serve as an alternative treatment: resveratrol and quercetin.

These particular drugs hold beneficial effects on arterial cells, such as healing, without any adverse side effects commonly seen in PAD therapies. The researcher’s goal was to use drugs that do not pose a threat to cells but rather restrict them from growing and narrowing an artery. "Dr. Dugas discovered that these two drugs in combination worked well for that purpose," said Crisitna Sabliov, LSU Biological and Agricultural Engineering professor. "She found the right potion, but she wanted the drugs released over time, and for that, she needed a smart delivery system. To be able to do that, Assistant Research Professor Carlos Astete and myself loaded these drugs into a nanoparticle," says Sabliov. "Nanoparticles are really, really small -- only 100-200 nanometers (nm). In comparison, a hair is 70,000 nm thick."

Researchers will seek to develop a drug-coated balloon (DCB) therapy where red wine compounds are sprayed evenly on the outside of a balloon in a nanoparticle can adhere to vessel walls, releasing the compound and preventing the growth of cells and narrowing of vessels to allow blood. "The whole procedure takes only a few minutes, so we need to make sure the particles are released from the balloon very quickly," said Sabliov.

However, research is never simple: "We have some challenges because, number one, you want the drugs released over time," Sabliov said. "And number two, the two different chemicals have to be in the optimum ratio that she [Dugas] finds works best. If they have a positive charge, then they attach quickly to the cells. "The ratio must be 1:2 because that's the magic potion that will make the drugs effective. We didn't want the drugs to kill the cells. We just wanted them to prevent the cells from growing back."

Learn more about peripheral artery disease (PAD):

Source: Louisiana State University, Journal of Biomedical Materials

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 27, 2020
Cardiology
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
OCT 27, 2020
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
When you pass by the nutrition section at the local grocery store, there is a chance you’ll come across row upon r ...
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
NOV 09, 2020
Drug Discovery & Development
COVID-19 Vaccine by Pfizer More than 90% Effective
NOV 09, 2020
COVID-19 Vaccine by Pfizer More than 90% Effective
A preliminary analysis of Pfizer and BioNTech's COVID-19 vaccine shows that it can prevent over 90% of people from c ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
Loading Comments...